# Review Result

RESULT: FAIL
REVIEW_VERDICT: FAIL
PROFILE_STATUS: absent
QUALITY_MODEL: Explicit Requirements / Minimal General Gate G1-G5

## Summary

The current OS-21 report remains within the requested measurement-and-diagnosis scope, preserves
the corpus and proposed-ticket structure, and resolves EXT-1: the observed `0/4` quantity is now
consistently described as a dispute/withdrawal rate, with `4/4` as an accepted-correction rate and
with repeated caveats that neither establishes correctness. The future references to a genuine
false-positive rate are limited to a proposed seeded fixture with a known answer key, where truth
adjudication would exist; they do not reinstate a false-positive claim for the current corpus.

EXT-2 is not fully resolved. Most of ANALYSIS.md and PLAN.md explicitly describe H-4 and H-5 as
not distinguishable and evidentially co-equal, but ANALYSIS.md still says one observation
"weakens H-5 slightly." That sentence assigns evidence against H-5 while the surrounding and
downstream text claims that neither hypothesis is evidentially ranked, leaving a material internal
contradiction in the root-cause assessment and violating the external review's required
evidence-bounded capability conclusion.

## Blocking Findings

ID: R3-1
Quality Attribute: G1
Severity: MAJOR
Blocking: YES
Responsible Phase: analysis
Location: `artifacts/runs/run_2c614077e685/ANALYSIS.md:265-278` (especially line 270)
Issue: The H-5 discussion still states that the #17 boundary-case detection "weakens H-5
slightly," while the same section and the propagated report state that H-4 and H-5 are
evidentially indistinguishable and co-equal.
Reason / Evidence: EXT-2 requires the capability explanation to remain "not distinguishable / not
ruled out by this corpus" unless a controlled reviewer-model/agent-assignment comparison is added,
and the attempt-3 instructions specifically require a whole-file check for any sentence that
implicitly favors H-4. No controlled comparison was added. Saying an uncontrolled observation
weakens H-5 is an evidentiary update against H-5; the immediate qualifier that it does not make
H-4 better supported does not reconcile that update with lines 273-278's claim that the two are
evidentially indistinguishable or with PLAN.md's repeated assertion that they are co-equal
everywhere. This residual asymmetry can bias the diagnosis and follow-up prioritization that OS-21
exists to validate.
Required Action: Remove or reframe the counter-indication so it is explicitly non-discriminating
between H-4 and H-5 on this corpus. Then propagate/check the wording in ANALYSIS.md and PLAN.md so
the documents no longer claim both that H-5 is weakened and that the hypotheses are evidentially
co-equal, and repeat the applicable phase review before a fresh Final Adversarial Review.

## Non-Blocking Findings

None.

## Test Review

No unit tests apply because the deliverable is documentation/evidence only. Direct validation
performed:

- Confirmed `.orca/quality-profile.yaml` is absent, so the Explicit Requirements / Minimal General
  Gate applies without a broad generic checklist.
- Read the current ANALYSIS.md and PLAN.md and searched both whole files for false-positive,
  dispute/withdrawal, accepted-correction, adjudication, H-4/H-5, capability, ranking, and
  distinguishability language.
- Confirmed EXT-1's current-corpus metrics are `0/4 dispute/withdrawal` and `4/4
  accepted-correction`, explicitly labeled as acceptance rather than correctness. Remaining
  positive uses of `false-positive rate` concern a proposed answer-key fixture where the metric
  would become measurable.
- Pulled the actual PR #19 review with `gh pr view 19 --json reviews` and verified its two MAJOR
  requirements against the current files.
- Confirmed PR #19 is OPEN and draft, targets `main`, and uses branch
  `agent/final-review-effectiveness-validation`; no merge or new PR was performed.
- Confirmed `git diff --name-status main...HEAD`, the current tracked diff, and the run-local
  untracked correction artifacts contain no production, lifecycle, prompt, VERSION, or LICENSE
  change. The branch's tracked changes relative to `main` are confined to
  `artifacts/runs/run_2c614077e685/`; current tracked edits are ANALYSIS.md, PLAN.md,
  ORCHESTRATOR_LOG.md, and TIMING_LOG.md in that directory.
- Confirmed all SHAs enumerated by PLAN.md V5 resolve as commits and representative referenced run
  artifacts exist. ORCHESTRATOR_LOG.md resolves the correction dispatch identities
  `task_92eb4e4149b6`/`ctx_983ff8240fc8`, `task_b42e83ac1cee`/`ctx_55012e7aa228`,
  `task_070112f8b00a`/`ctx_6064ce897404`, and `task_25d298d476ee`/`ctx_528ffa37bc7a`.
- `git diff --check -- artifacts/runs/run_2c614077e685` completed without whitespace errors.

## A-I Review Coverage

- A — Objective alignment: FAIL only for incomplete EXT-2 correction; the effectiveness report and
  requested sections otherwise remain present.
- B — Cross-phase consistency: FAIL because ANALYSIS.md's “weakens H-5 slightly” conflicts with
  both its own co-equality claim and PLAN.md's propagated co-equality assertions.
- C — Contract vs implementation: No production implementation change; explicit correction
  contract checked against the report text.
- D — Implementation vs tests: Not applicable; evidentiary validation is documented above.
- E — Docs vs behavior: PR/run state and repository identities checked directly.
- F — Lifecycle state machine: No lifecycle semantics changed; iteration-4 analysis correction and
  iteration-3 plan revalidation are recorded in the run logs.
- G — Security/destructive scope: No destructive, secret-bearing, or forbidden file change found.
- H — Over-engineering: No large fix or scope expansion was implemented.
- I — Hidden coupling: No production/shared contract, VERSION, LICENSE, Risk, Quality Profile, or
  Agent Profile change found.

The external review did not cause inappropriate dilution elsewhere: the five-case corpus, `0/5`
external blocking recall, negative-space archetype, H-1/H-2 hedging, auditability/reproducibility
findings, and eight separately root-caused follow-up tickets remain present. This preservation does
not cure R3-1 because root-cause neutrality is itself an explicit correction requirement.

## Final Decision

FAIL. One MAJOR blocking G1 finding remains in the analysis phase, so attempt 3 cannot authorize
completion. The correction loop should resolve R3-1 in ANALYSIS.md, revalidate PLAN.md downstream
under the HIGH-risk contract, and then run a fresh Final Adversarial Review within the remaining
iteration budget.
